.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Epinephrine; lidocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for epinephrine; lidocaine hydrochloride?

Epinephrine; lidocaine hydrochloride is the generic ingredient in nine branded drugs marketed by Intl Medication, Belmora Llc, Vyteris, Eurohlth Intl Sarl, Astrazeneca, Carlisle, Bel Mar, Pharmaton, Iomed, Hospira, Septodont, Abbott, Eastman Kodak, Watson Labs, Dentsply Pharm, Empi, Fresenius Kabi Usa, and Dell Labs, and is included in thirty-one NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Epinephrine; lidocaine hydrochloride has eight patent family members in seven countries.

There are nineteen drug master file entries for epinephrine; lidocaine hydrochloride. Twelve suppliers are listed for this compound.

Summary for Generic Name: epinephrine; lidocaine hydrochloride

Tradenames:9
Patents:3
Applicants:18
NDAs:31
Drug Master File Entries: see list19
Suppliers / Packagers: see list12
Clinical Trials: see list1,451
Drug Prices:see low prices
DailyMed Link:epinephrine; lidocaine hydrochloride at DailyMed

Pharmacology for Ingredient: epinephrine; lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION089650-001Jun 21, 1988DISCNNoNo► Subscribe► Subscribe
Pharmaton
LIDOCATON
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION084728-001Aug 17, 1983DISCNNoNo► Subscribe► Subscribe
Dell Labs
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION083389-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Empi
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
SOLUTION;IONTOPHORESIS, TOPICAL021486-001Oct 26, 2004DISCNNoNo► Subscribe► Subscribe
Bel Mar
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION080820-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: epinephrine; lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vyteris
LIDOSITE TOPICAL SYSTEM KIT
epinephrine; lidocaine hydrochloride
PATCH;IONTOPHORESIS, TOPICAL021504-001May 6, 20045,246,418► Subscribe
Vyteris
LIDOSITE TOPICAL SYSTEM KIT
epinephrine; lidocaine hydrochloride
PATCH;IONTOPHORESIS, TOPICAL021504-001May 6, 20045,873,850► Subscribe
Vyteris
LIDOSITE TOPICAL SYSTEM KIT
epinephrine; lidocaine hydrochloride
PATCH;IONTOPHORESIS, TOPICAL021504-001May 6, 20046,862,473► Subscribe
Vyteris
LIDOSITE TOPICAL SYSTEM KIT
epinephrine; lidocaine hydrochloride
PATCH;IONTOPHORESIS, TOPICAL021504-001May 6, 20046,385,488► Subscribe
Vyteris
LIDOSITE TOPICAL SYSTEM KIT
epinephrine; lidocaine hydrochloride
PATCH;IONTOPHORESIS, TOPICAL021504-001May 6, 20046,377,847► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: epinephrine; lidocaine hydrochloride

Country Document Number Estimated Expiration
Australia7310401► Subscribe
Germany60129965► Subscribe
European Patent Office1294439► Subscribe
Japan4024673► Subscribe
Austria369891► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc